[1]
D. Liu, G. Yu, N. Yuan, and D. Nie, “The efficacy and safety of biologic or targeted synthetic DMARDs in rheumatoid arthritis treatment: one year of review 2024”, Allergol Immunopathol, vol. 53, no. 3, pp. 140–162, May 2025, doi: 10.15586/aei.v53i3.1278.